X

Health Care

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research…

Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results

Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As…

Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results

Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter…

Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.…

Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights

Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues…

Gilead Sciences reports Q3 earnings. Here’s everything you need to know

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of…

Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results

Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit.…

VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results

Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The…

Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of…

REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third…

Main highlights from Eli Lilly’s (LLY) Q3 2023 earnings results

Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37%…

Cigna Group (CI) Q3 2023 Earnings: Key financials and quarterly highlights

The Cigna Group (NYSE: CI) reported third quarter 2023 earnings results today. Total revenues increased 8% to $49 billion compared to…

Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results

IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences…

CVS Health (CVS) Q3 2023 Earnings: Key financials and quarterly highlights

CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion.…

Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results

Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter…

AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results

Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023.…

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company…

BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…

Merck (MRK) Earnings: 3Q23 Key Numbers

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period…

ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The…